Our study is the largest monocentric study reported thus far, aiming to systematically evaluate the prognostic value of BCR-ABL1 transcripts in adult patients with Ph+ ALL treated with relatively uniform regimens. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.